홈 › 전이성 암 › 오하이오

오하이오의 전이성 암 임상 시험

전이성 암 관련 연구 59개가 오하이오 내 여러 지역에서 참여자를 모집하고 있습니다.

오하이오의 도시

공식 연구 텍스트(영어)

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Clinical Study Site, Columbus

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07335497

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

OhioHealth O'Bleness Hospital, Athens
UH Seidman Cancer Center at UH Avon Health Center, Avon
UHHS-Chagrin Highlands Medical Center, Beachwood
외 41개

피험자 모집 중2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Ohio State University Comprehensive Cancer Center, Columbus

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05372614

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Cleveland Clinic, Cleveland

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT04886804

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Gabrail Cancer Center, Canton

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

University of Cincinnati Cancer Center, Cincinnati
Taylor Cancer Research Center, Maumee

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07562152

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

OSU Brain & Spine Hospital, Columbus

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT05384626

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Cleveland Clinic, Cleveland

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Cleveland Clinic Akron General, Akron
Aultman Hospital, Canton
Gabrail Cancer Center, Canton
외 4개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University Hospitals Cleveland Medical Center, Cleveland

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Miami Valley Hospital South, Centerville
University of Cincinnati Medical Center, Cincinnati
Oncology Hematology Care Inc, Cincinnati
외 7개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Miami Valley Hospital South, Centerville
USO - Oncology Hematology Care, Cincinnati
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

University of Cincinnati Medical Center (UCMC), Cincinnati
The Ohio State University (OSU), Columbus

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05614739

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Gabrail Cancer & Research Center, Canton

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05856981

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

University Hospitals Cleveland Medical Center, Cleveland
The Ohio State University Comprehensive Cancer Center, Columbus

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06943755

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

University Hospitals - UH Cleveland Medical Center, Cleveland

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07094204

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
University of Cincinnati Cancer Center-West Chester, West Chester

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT05803382

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 or 2 Systemic Treatment Regimens

Cleveland Clinic, Cleveland
The Ohio State University Comprehensive Cancer Center, Columbus

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06127407

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ohio State University, Columbus

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT06769698

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Oncology Hematology Care Primary, Cincinnati
Taylor Cancer Research Center, Maumee

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT04657068

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

The Ohio State University Comprehensive Cancer Center, Columbus

피험자 모집 중1상

18세 이상 · 남성 · 2026. 10. 20. 업데이트됨 · NCT07103018

REMASTer: REcurrent Brain Metastases After SRS Trial

Cleveland Clinic, Cleveland
Kettering Health, Kettering

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT05124912

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Ohio State University Comprehensive Cancer Center, Columbus

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06311214

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

OSU Brain and Spine Hospital, Columbus

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT06521554

A Study of ASP3082 in Adults With Advanced Solid Tumors

Case Western, Cleveland
Taylor Cancer Research Center, Maumee

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT05382559

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06757634

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Aultman Hospital, Canton
Aultman Medical Group Hematology and Oncology, Canton
Oncology Hematology Care Clinical Trials, Cincinnati
외 7개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07222566

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Oncology Hematology Care - Eastgate, Cincinnati
University Hospitals Cleveland Medical Center, Cleveland
Oncology Hematology Care Clinical Trials, LLC, Fairfield

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07222800

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

University of Cincinnati Medical Center, Cincinnati
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT07218380